EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    Sustainable Pharma Manufacturing: Eco-Friendly Practices for the Pharmaceutical Industry

    The pharmaceutical business is of significant importance to the healthcare sector all over the world yet it is also among the manufacturing industries that are resourceconsuming Energyintensive production processes complicated chemical synthesis and mass packaging processes have all contributed to pollution and emissions of carbon emissions to the environment as part of the traditional drug manufa...

    Role of Artificial Intelligence in Pharmaceutical Industry

    The global AI in the pharma market expanded to a size of nearly million in The market is anticipated to increase at a rate of from million in to million in Researchers claim that the application of these technologies enhances decisionmaking maximizes creativity increases the effectiveness of research and clinical trials

    Risk Management in Pharmaceutical Manufacturing

    The pharmaceutical industry operates under strict regulatory oversight because medicines directly affect patient health and safety Manufacturers must consistently produce products that meet predefined standards of quality safety efficacy identity strength and purity Achieving these objectives requires a proactive approach to identifying and controlling risks throughout the product lifecycle

    Pharma ABM Strategies for B2B Growth: Precision Targeting for Key Accounts

    The pharmaceutical industry is making significant strides changing the way that company ies are identified engaged and converted into high value business customers In todays datadriven competitive world traditional mass marketing strategies are no longer effective In todays day and age pharmaceutical companies are embracing very personalized relationships ROI measurement and the expansion of their...

    The Impact of AI and Machine Learning on Drug Discovery

    Now and then an industry hits a point where the old ways no matter how trusted start to feel a bit like trying to run a marathon in hiking boots Drug discovery is in that spot For decades pharmaceutical RD leaned heavily on long painstaking experiments and the occasional stroke of luck Entire teams would spend years nudging molecules around waiting for a hint that something might work After all th...

    Pharmaceutical Business Strategy: Transformation, Regulation, Outsourcing and Growth

    The pharmaceutical industry is standing at an unusual crossroads Patent cliffs are steeper regulators are tougher patients expect more transparency and payers are pushing back harder on price In this environment a strong Pharma Business Strategy is no longer a slide deck exercise for the boardroom its the difference between a company that scales globally and one that quietly fades into irrelevanc...

TOP ARTICLES

  • 2

    Risk Management in Pharmaceutical Manufacturing

    Venkata Reddy Pothireddy

    Risk management is a critical element of pharmaceutical manufacturing that supports product quality, patient safety, regulatory compliance, and business continuity. As manufacturing processes become m...

  • 4

    The Impact of AI and Machine Learning on Drug Discovery

    Satyajit Shinde

    Artificial intelligence (AI) and machine learning (ML) are revolutionising drug discovery by dramatically accelerating the identification and development of new therapies. These technologies analyse v...

press releases Read more...

HCW Biologics Strengthens U.S. Patent Estate for Its Lead Clinical-Stage Immunotherapeutic HCW9302 as Alopecia Areata Treatment

HCW Biologics Inc the Company or HCW Biologics NASDAQ HCWB a USbased clinicalstage biopharmaceutical company focused on developing novel fusion immunotherapeutics to treat autoimmune

UniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease

UniQure NV NASDAQ QURE a leading gene therapy company advancing transformative therapies for patients with severe medical needs today announced the submission of a Biologics License Application

Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

Telix Pharmaceuticals Limited today announced completion of patient enrollment in the Phase BiPASS study of its commercial PSMAPET imaging agents Illuccix kit for the preparation of gallium

AstraZeneca completes global license agreement for oral EGFR inhibitor ZEGFROVY® (sunvozertinib) for lung cancer

AstraZeneca today announced the successful completion of the previously announced exclusive license agreement with Dizal Pharmaceutical Co Ltd for ZEGFROVY sunvozertinib an oral irreversible epidermal

03 - 05

Sep 2026

5th MENA Congress for Rare Diseases 2026

Beach Rotana Hotel, Abu Dhabi,...

14 - 15

Sep 2026

16th American DDF Summit

Omni Boston Hotel at the Seapo...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

28 - 01

Sep 2026

LATEST NEWS Read more...

Evotec and Plectonic Enter Research Collaboration to Explore New T-Cell-Engaging Approaches for Solid Tumours

Evotec SE and Plectonic Biotech have entered a research collaboration to explore a new immunotherapy approach for solid tumours The partnership will combine Plectonics programmable LOGIBODY

NewBiologix and Synastra Biotechnology Partner to Advance Stable rAAV Manufacturing for Duchenne Muscular Dystrophy Gene Therapy

NewBiologix SA and Synastra Biotechnology Inc have entered into an agreement to develop a stable producer cell line for Synastras investigational gene therapy programme for Duchenne muscular dystrophy DMD

Styx Biotechnologies and ZoeNCure Therapeutics Sign Strategic Agreement to Advance ADC Pipeline

Styx Biotechnologies a San Diegobased biotechnology company developing nextgeneration antibodydrug conjugates ADCs for solid tumours has entered into a strategic agreement with ZoeNCure Therapeutics Pvt Ltd to advance selected ADC programmes towards firstinhuman clinical trials

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Expands Executive Leadership Team

Vertex Pharmaceuticals Incorporated Nasdaq VRTX has completed its acquisition of Crinetics Pharmaceuticals Inc Nasdaq CRNX a pharmaceutical company focused on developing treatments for endocrine diseases Vertex has also expanded its executive leadership team as it continues to grow and diversify its...

Eclipsebio Launches Nanopore-Based Assay for Multi-Attribute RNA Characterisation

Eclipse Bioinnovations Inc Eclipsebio a provider of sequencingbased analytics and AIenabled design for RNA therapeutics has launched eSTRAND RNA QC a nanoporebased assay designed to provide multiattribute RNA characterisation

4basebio and Genezen Expand Collaboration on Synthetic DNA for Viral Vector Manufacturing

basebio PLC a specialist in enzymatically produced cellfree DNA for genetic medicines has expanded its collaboration with viral vector contract development and manufacturing organisation CDMO Genezen